These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Pharmacotherapy of hyperlipoproteinemias: indications, mechanisms of action, effectiveness and side effects]. Schernthaner G, Woschnagg H. Wien Med Wochenschr; 1990 Feb 15; 140(3):64-75. PubMed ID: 2180212 [Abstract] [Full Text] [Related]
27. [Basic principles of drug therapy of hyperlipoproteinemia]. Romics L. Orv Hetil; 1988 Nov 06; 129(45):2391-9. PubMed ID: 3054710 [No Abstract] [Full Text] [Related]
30. [Etolip and Lipanthyl in the treatment of hyperlipoproteinemia]. Ceska R, Sobra J, Procházková R, Kvasilová M. Vnitr Lek; 1990 Apr 06; 36(4):363-7. PubMed ID: 2356612 [Abstract] [Full Text] [Related]
31. [Drug therapy of hyperlipoproteinemia]. Steinmetz A, Kaffarnik H. Internist (Berl); 1992 Jan 06; 33(1):44-53. PubMed ID: 1551763 [No Abstract] [Full Text] [Related]
32. [A comparison of the hypolipidemic action of probucol at doses of 500 and 1000 mg/day in moderate hyperlipoproteinemia]. Tvorogova MG, Lupanov VP, Nuraliev EIu, Zaĭtseva TM, Kukharchuk VV, Titov VN. Ter Arkh; 1998 Jan 06; 70(8):17-21. PubMed ID: 9770737 [Abstract] [Full Text] [Related]
33. Drug treatment of hyperlipoproteinaemia. Romics L. Ther Hung; 1983 Jan 06; 31(4):152-60. PubMed ID: 6400456 [No Abstract] [Full Text] [Related]
36. [Ciprofibrate in the treatment of combined hyperlipoproteinemia. Results in more than 600 patients from 23 centers in the Czech Republic]. Ceska R, Kvasnicka T, Haas T, Soska V, Vaverková H. Vnitr Lek; 2000 Mar 06; 46(3):157-60. PubMed ID: 11048518 [Abstract] [Full Text] [Related]
37. [level of 7alpha-hydroxycholesterol in blood plasma as an indicator of cholesterol catabolism in hyperlipidemia and with hypolipidemic therapy]. Poliakova ED, Ivanova TN, Voshchinnikov EI, Olfer'ev AM, Perova NV. Vopr Med Khim; 2000 Mar 06; 46(2):168-75. PubMed ID: 10885038 [Abstract] [Full Text] [Related]